The equity raise is now open to qualified investors. You may register to receive the Information Memorandum (“IM”) by entering your details opposite. You will receive a confirmation email and then we will send you the IM or we may contact you for further verification. The document is only suitable for certain qualified investors and no subscriptions will be accepted from investors who do not fit the categories outlined in the IM.
Thank you for your interest in ASMX!
The investment opportunity detailed in the Information Memorandum (“IM”) may not be suitable for all recipients. If you are in any doubt about the action you should take in regard to the document and its contents and appendices (including the Subscription Form) you are strongly recommended to consult an Independent Financial Advisor authorised by the Financial Conduct Authority (“FCA”), who specialises in investments of this nature before making a decision to invest. Reliance on this promotion for the purpose of engaging in any investment activity may expose an individual’s investment to a number of significant risks. Nothing in the document constitutes investment, tax, financial or other advice.
The content of the IM has been prepared by the Directors of ASMX Limited (referred to from hereon in as “the Company”) and has been approved as of 13th June 2019 as a financial promotion by Marshall Sterling Regulatory Compliance and Law (“MS”, “Marshall Sterling”) which is a trading name of Marshall Sterling Investment Management Limited which is Authorised and Regulated by the Financial Conduct Authority (“FCA”) under firm reference number 646917 in accordance with the provisions of Section 21 of the Financial Services and Markets Act 2000 (“FSMA”). In approving the campaign, Marshall Sterling has concluded that the information, taken as a whole, is “fair, clear and not misleading.” This means that for factual statements they have reviewed evidence of their accuracy, and that for aspirational statements they believe they are phrased appropriately in light of their nature. You should note that in the case of factual statements, the evidence reviewed is provided by the business, and MS do not audit it, which means that they may not be able to identify altered evidence. You should further note that in the case of aspirational statements, the Directors are likely to have high ambitions, and MS may approve statements that convey those ambitions even where MS do not have a view on whether it is likely, that they will be fully realised.